Collaboration announced at the HLTH conference in Las Vegas explores consumer interaction with conversational medical AI.
Apple and OpenEvidence announced a new study featuring an experimental, artificial intelligence-driven health chat application. The initiative was unveiled on Sunday at the HLTH conference in Las Vegas by Apple Vice President of Health and Fitness Sumbul Desai and OpenEvidence CEO Daniel Nadler.
According to Desai, Apple’s focus on scientific rigor drove the partnership, which is designed to evaluate how consumers engage with conversational health AI. The research focuses on identifying what fosters user trust, assessing response quality, and examining how people understand AI-generated health information by teaming up with a clinically grounded partner.
Nadler described the collaboration as a fusion of consumer trust and medical expertise, noting that OpenEvidence is widely utilized by physicians while Apple maintains a strong following among health consumers. The experimental application represents a new exploratory step for both organizations in the digital health space.

